Cell Signaling Technology

nSMase1 Antibody

#3867 · $317

100
Citing papers
10k
Combined citations
Supplier page Find this product

Research areas

PI3K/AKT/mTOR signaling in cancer13Endoplasmic Reticulum Stress and Disease8Autophagy in Disease and Therapy8Ubiquitin and proteasome pathways7Prostate Cancer Treatment and Research6Immune Cell Function and Interaction5Estrogen and related hormone effects5Neurogenesis and neuroplasticity mechanisms5

Papers citing this product

1
Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
American Journal Of Pathology·2012·323 cit.·DOI
2
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer
Endocrine Related Cancer·2011·299 cit.·DOI
3
Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
International Journal of Molecular Sciences·2021·288 cit.·DOI
4
Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery
Scientific Reports·2016·244 cit.·DOI
5
Cancer Causes Cardiac Atrophy and Autophagy in a Sexually Dimorphic Manner
Cancer Research·2010·214 cit.·DOI
6
Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children
Experimental & Molecular Medicine·2020·210 cit.·DOI
7
Comprehensive Functional Annotation of 77 Prostate Cancer Risk Loci
PLoS Genetics·2014·196 cit.·DOI
8
Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils
Journal of Experimental & Clinical Cancer Research·2019·191 cit.·DOI
9
CCL2 Mediates Neuron–Macrophage Interactions to Drive Proregenerative Macrophage Activation Following Preconditioning Injury
Journal of Neuroscience·2015·189 cit.·DOI
10
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Breast Cancer Research·2011·184 cit.·DOI